This new fundraising secures the financing of its Phase IIB study for HepaStem® in its flagship indication, Acute on Chronic Liver Failure (ACLF), a severe liver disease affecting more than 50000 patients each year in EU and USA , with a 40% to 70% mortality. Mont-Saint-Guibert, Belgium, 30th June 2021...
Read More
Univercells S.A. (the “Company”) announces a rebranding of its visual identity and update of its mission to reflect the evolution of the Company over the years. Coinciding with the unveiling of its new identity, Univercells launches a new corporate website (www.univercells.com) focusing on the Group’s vision, mission, and ambition. “The...
Read More
Communiqué de presse - Gosselies, le 30 juin 2021 Feu vert pour le ‘EU Biotech School & Health Hub’ à Gosselies Investissement de 25 millions d'euros dans un projet clé pour le développement international de la biotechnologie et de la biopharmacie en Wallonie Former plus de talents et soutenir plus...
Read More
ULB HelSci launches an INTERUNIVERSITY CERTIFICATE IN VACCINOLOGY Come and train yourself in the scientific, sociological and communication aspects related to vaccination! 📅 From October 2021 The first edition of this training, which will combine digital courses and face-to-face sessions, will start in October 2021. This is an innovative certificate...
Read More
IBA Launches Versatile High-Energy New Cyclotron Last June, IBA unveiled its new Cyclone® IKON. 35 years of experience and innovation concentrated in the new versatile, high-energy cyclotron for enhanced availability of theranostic radiopharmaceuticals and reduced radiopharmacy footprint. Cyclone® IKON offers the largest energy spectrum for PET and SPECT isotopes from...
Read More
3rd edition of HealthTech Innovation Days (4 & 5 October 2021) HealthTech For Care and EIT Health announce the opening of applications for European companies Paris, France, April 8, 2021 - HealthTech Innovation Days (HTID®) has become the reference event for European innovative healthcare companies that want to accelerate their...
Read More
Jumet (Belgium), March 30, 2021 – GRAFTYS SA ("Graftys"), a global leader in resorbable bone cements, announces today the opening of its new preparation and logistic site in Liège (Belgium). Continuously strengthening its manufacturing capability and reinforcing its logistic services to improve the quality of its products and the performance...
Read More
GERMANTOWN, Md., March 29, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, announces that it has entered a collaboration with the Bambino Gesù Children's Hospital in Rome to establish a Point of Care Cell Therapy center...
Read More
Athens, Georgia, USA – March 24, 2021 – CyanVac LLC, a vaccine company, announced today that they have selected Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), for the development and manufacturing of their COVID-19 intranasal vaccine based on a proprietary parainfluenza virus 5 (PIV5) vector. Exothera will be...
Read More
Launch of the 2nd call for collective projects Tremplin IA Within the framework of the Enterprise and AI axis of the DigitalWallonia4.ai program, the 2nd call for “collective POC” projects has been launched. Within the framework of the Enterprise and AI axis of the DigitalWallonia4.ai program, the 2nd call for “collective POC”…